期刊文献+

血液净化方式对尿毒症血同型半胱氨酸的清除效果 被引量:7

Effect of different blood purification methods on homocysteine in uremic patients
下载PDF
导出
摘要 目的探讨血液净化模式对维持性血液透析(maintaince hemodialysis,MHD)患者血同型半胱氨酸的清除效果。方法 120例患者随机分为血液透析组、血液透析滤过组、高通量透析组、高通量透析+血液灌流组,每组30人。治疗6个月后,分别测定各组同型半胱氨酸(Hcy)水平。结果血液透析组Hcy没有变化,其他三组明显下降,其中高通量透析+血液灌流组最为显著,并且有统计学意义,P<0.05。结论高通血液透析+血液灌流能显著降低尿毒症患者Hcy水平,防止心血管事件发生,提高生活质量。 Objective To investigate the effect of different blood purification modes on homocysteine clearance in patients with maintenance hemodialysis( MHD). Methods A total of one hundred and twenty patients were randomly divided into hemodialysis group,hemodialysis filtration group,high-flux dialysis group,and high-flux dialysis + hemoperfusion group,with 30 patients in each group. Six months after treatment,homocysteine levels were measured in each group. Results The levels of Hcy remained unchanged in hemodialysis group,and decreased significantly in the other three groups,especially in high-flux hemodialysis + hemoperfusion group( P〈0. 05).Conclusions Hyperventilation and hemoperfusion can significantly reduce Hcy levels,prevent cardiovascular events and improve the quality of life in uremic patients.
作者 任永强 魏雅娟 陈海英 朱冬燕 REN Yongqiang;WEI Yajuan;CHEN Haiying;ZHU Dongyan(Department of Nephrology;Internal one family, 3. Med- ical Service;Medical Service, Beijing Municipal Corps Third Hospital of the Chinese People' s Armed Police Force, Beijing 100141, China)
出处 《武警医学》 CAS 2018年第4期351-352,357,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 尿毒症 血液透析 血液灌流 高同型半胱氨酸 uremia hemodialysis blood perfusion homocysteine
  • 相关文献

二级参考文献34

  • 1范连慧,吴雄飞,赵洪雯,余荣杰,干磊,刘宏,孙岩,金锡御.CRRT在顽固性频发心衰尿毒症患者肾移植中的应用[J].第三军医大学学报,2004,26(9):805-807. 被引量:18
  • 2叶云洁,倪兆慧,钱家麒,何颖欣.终末期肾病微炎症状态和动脉粥样硬化的关系[J].中华肾脏病杂志,2004,20(3):173-176. 被引量:94
  • 3陈朝生,徐玉兰,梅晓蓉,许菲菲,郑尘非,刘毅,王绿萍,黄朝兴.高通量血透对血浆同型半胱氨酸和超敏C反应蛋白的影响[J].中华肾脏病杂志,2006,22(8):506-507. 被引量:16
  • 4赵建荣,黄宇玮,茆亦一,陆强.高血压病患者血浆同型半胱氨酸与血脂关系研究[J].实用全科医学,2007,5(1):5-6. 被引量:32
  • 5Tremblay R, Bonnardeaux A, Geadah D Hyperhomocysteinemia in hemodialysis patients: 12-month supplementation with hydro soluble Kidney Int, 2000, 58: 851-858. et al. effects of.
  • 6Massy ZA, Ceballos I, Chadefaux-Vekemens B, et al. Homocysteine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl, 2001, 78: 243-245.
  • 7Perma AF, Ingrosso D, Castaldo P, et al. Homocysteine and chromic renal failure. Miner Electrolyte Metab, 1999, 25: 279-285.
  • 8Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor. Blood Purif, 2000, 18: 177-182.
  • 9Tamura T, Johnston K, Bergman SM. Homocysteine and folate concentrations in blood from patients treated with hemodialysis. J Am Soc Nephrol, 1996, 7: 2414-2418.
  • 10Chambers TC, Ueland PM, Wright M, et al. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subject. Circ Res, 2110, 89: 187-192.

共引文献38

同被引文献75

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部